IL17A and cerebral infarction: The miR-137 downregulated Src reducing cerebral infarction volume by inhibiting release of inflammatory markers such as TNF-α, IL-1, IL-6 and IL-17, p-ERK 1/2, p-38, and p-JNK and also improving cognitive functions in MCAO rats.